Skip to content

Optimal duration of proton pump inhibitor treatment for endoscopic submucosal dissection-induced ulcers

Optimal duration of proton pump inhibitor treatment for endoscopic submucosal dissection-induced ulcers - ESDPPI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000004415
Enrollment
50
Registered
2010-10-20
Start date
2005-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric mucosal neoplasm

Interventions

None listed

Sponsors

Third Department of Internal Medicine, University of Toyama
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent ESD for gastric mucosal neoplasm

Exclusion criteria

Exclusion criteria: serious complications including cardiac, haematological, renal and/or hepatic disease

Design outcomes

Primary

MeasureTime frame
At 8 weeks after ESD, % S stages Patients.

Secondary

MeasureTime frame
The size of the ulcer after ESD Ulcer stage after ESD

Countries

Japan

Contacts

Public ContactShinya Kajiura

University of Toyama Department of Gastroenterology

shin-ya@nsknet.or.jp081-76-434-7301

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026